Securities code: 300791 securities abbreviation: Sirio Pharma Co.Ltd(300791) announcement Code: 2022-003 securities code: 123113 securities abbreviation: xianle convertible bonds
Announcement on reappointment of audit institutions in 2021
The company and all members of the board of directors guarantee that the content of information disclosure is true, accurate and complete
There are false records, misleading statements or major omissions.
Sirio Pharma Co.Ltd(300791) (hereinafter referred to as “the company”) held the sixth meeting of the third board of directors on January 24, 2022, deliberated and approved the proposal on renewing the appointment of the audit institution in 2021, and agreed to appoint Huaxing Certified Public Accountants (special general partnership) as the audit institution of the company in 2021, Meanwhile, the general meeting of shareholders is requested to authorize the management of the company to determine the audit fee with Huaxing Certified Public Accountants (special general partnership). This proposal still needs to be submitted to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation. The details are hereby announced as follows:
1、 Description of the proposed accounting firm
Huaxing Certified Public Accountants (special general partnership) (hereinafter referred to as “Huaxing certified public accountants”) has the qualification of securities and futures related business, and has successfully completed the relevant audit work during the period of serving as the audit institution of the company in 2020 and the special audit institution of the company issuing convertible corporate bonds to unspecified objects. Upon the proposal of the audit committee of the board of directors and the prior approval of all independent directors, the board of directors deliberated and agreed to appoint Huaxing firm as the audit institution of the company in 2021, and requested the general meeting of shareholders to authorize the management of the company to determine the audit fee with Huaxing firm.
2、 Basic information of the accounting firm to be employed
1. Institutional information
(1) Organization Name: Huaxing Certified Public Accountants (special general partnership)
(2) Organization type: special general partnership
(4) History: Huaxing certified public accountants, formerly Fujian Huaxing certified public accountants, was founded in 1981 and is subordinate to the Department of finance of Fujian Province. In December 1998, it was decoupled from the former competent unit Fujian Provincial Department of Finance and restructured into Fujian Huaxing limited liability accounting firm. From January 1, 2009, it was renamed Fujian Huaxing Accounting Firm Co., Ltd. and on December 9, 2013, it was transformed into Fujian Huaxing accounting firm (special general partnership). In July 2019, it was renamed Huaxing Certified Public Accountants (special general partnership).
(5) Business qualification: Huaxing firm has obtained the qualification of securities and futures, the membership of inter-bank market dealers association and the qualification of security and confidentiality of military secret related business consulting services. It is one of the first accounting firms to obtain the qualification of securities and futures related business in China. Huaxing firm has been engaged in securities service business for more than 20 years.
(6) Investor protection ability: as of December 31, 2020, Huaxing office has purchased occupational insurance with a cumulative compensation limit of 80 million yuan, and the provision of occupational risk fund and the purchase of occupational insurance comply with relevant regulations.
Huaxing firm has not had any civil litigation caused by its practice in recent three years.
2. Personnel information
As of December 31, 2020, Huaxing firm has 42 partners, 330 certified public accountants, and the chief partner is Mr. Lin Baoming, of which more than 130 certified public accountants have signed the audit report of securities service business.
3. Business information
In 2020, the business income of Huaxing firm was 326.6896 million yuan, including audit income of 300.4198 million yuan and securities business income of 168.1774 million yuan. In 2021, it has provided audit services for 77 listed companies in 2020 annual report. The main industries of listed companies are manufacturing (including computer, communication and other electronic equipment manufacturing, chemical raw materials and chemical products manufacturing, electrical machinery and equipment manufacturing, pharmaceutical manufacturing, rubber and plastic products industry, textile and clothing industry, clothing industry, etc.), construction industry, culture Sports and entertainment industry, water conservancy, environment and public facilities management industry, transportation, warehousing and postal industry, etc.
4. Practice information and professional competence
Huaxing firm and its employees do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants.
Guo Xiaojun, partner of the signing project, a certified public accountant in China, has been engaged in securities service business for more than 19 years. So far, he has provided securities services such as IPO declaration audit, annual report audit of listed companies and major asset restructuring audit for many listed companies, and has corresponding professional competence. The project partner has no part-time job. In the past three years, we have signed and reviewed the audit reports of many listed companies and listed companies, such as Jinfa Labi Maternity & Baby Articles Co.Ltd(002762) , Sirio Pharma Co.Ltd(300791) , Novoray Corporation(688300) , Biem.L.Fdlkk Garment Co.Ltd(002832) .
He Ting, the signing certified public accountant in this period, has been engaged in securities service business for more than 11 years. So far, he has provided securities services such as IPO declaration audit, annual report audit and refinancing audit for many listed companies, and has corresponding professional competence. The above-mentioned accountant to be signed has no part-time job. In recent three years, we have signed and reviewed the audit reports of Sirio Pharma Co.Ltd(300791) , runke biology and other listed companies and listed companies.
Ni Mingzhao, reviewer of project quality control, is a certified public accountant in China. He has been engaged in securities service business for 19 years. He is responsible for auditing and reviewing several listed companies and has corresponding professional competence. Six audit reports of listed companies have been reviewed in the past three years.
5. Integrity record
Huaxing firm has not been subject to criminal punishment, administrative punishment and self-discipline supervision measures in the past three years. In November 2019, we received a copy of the decision on administrative supervision measures of Xiamen securities regulatory bureau with the document No. “decision on administrative supervision measures of Xiamen regulatory bureau of China Securities Regulatory Commission [2019] No. 18”. According to the provisions of relevant laws and regulations, the above-mentioned administrative supervision measures will not affect Huaxing’s continued undertaking or execution of securities service industry and other businesses.
Guo Xiaojun, the project partner, he Ting, the signing certified public accountant and Ni Mingzhao, the reviewer of project quality control, have not been subject to criminal punishment, administrative punishment, administrative supervision measures and self-discipline punishment in recent three years.
6. Independence
Huaxing certified public accountants and the above personnel do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants.
7. Audit fees
Pricing principle of audit fees: the final audit fees shall be determined according to the company’s business scale, industry, complexity of accounting treatment and other factors, as well as the auditors required for the audit of the company’s annual report, the workload invested and the charging standard of the firm.
3、 Examination and approval procedures to be performed by the accounting firm to be reappointed
1. Deliberations of the board of Auditors
The audit committee of the third board of directors of the company reviewed Huaxing firm and considered that Huaxing firm has independence, professional audit ability and qualification and investor protection ability, and can meet the audit requirements of the company. It is proposed that the board of directors appoint Huaxing firm as the audit institution of the company in 2021 and submit the proposal to the board of directors of the company for deliberation.
2. Prior approval opinions of independent directors
Huaxing firm has the practice certificate of accounting firm and the practice qualification of securities and futures related businesses, has the experience and ability to provide audit services for listed companies, and can provide fair, fair and independent audit services for the company. This appointment is based on the needs of the company’s business development, complies with relevant laws, regulations and the articles of association, and does not damage the interests of the company and other shareholders, especially the interests of minority shareholders. Therefore, all independent directors unanimously approved and agreed to submit the proposal on renewing the appointment of audit institution in 2021 to the sixth meeting of the third board of directors of the company for deliberation.
4. Independent opinions of independent directors
Huaxing firm has the qualification of securities, futures and other related businesses. In providing the company with 2020 financial report audit services, it strictly abides by professional ethics, follows the independent, objective and fair practice standards, successfully completed the 2020 audit business, and has the professional ability to provide the company with financial report audit services, Meet the requirements of the company’s audit in 2021. The procedures for the renewal of Huaxing firm as the company’s audit institution in 2021 comply with the provisions of relevant laws, regulations and the articles of association, and there is no damage to the interests of the company and shareholders (especially the interests of minority shareholders). Therefore, all independent directors unanimously agreed to reappoint Huaxing firm as the company’s audit institution in 2021.
5. Deliberations of the board of directors
At the sixth meeting of the third board of directors held on January 24, 2021, the company deliberated and approved the proposal on renewing the appointment of 2021 audit institution, and agreed to appoint Huaxing firm as the company’s 2021 audit institution.
6. Other matters that need to be explained need to be submitted to the general meeting of shareholders of the company for deliberation. 3、 Documents for future reference 1. Resolutions of the sixth meeting of the third board of directors; 2. Prior approval opinions of independent directors on matters related to the sixth meeting of the third board of directors of the company; 3. Independent opinions of independent directors on matters related to the sixth meeting of the third board of directors of the company; 4. Resolutions of the third meeting of the audit committee of the third board of directors; 5. Relevant qualification documents of Huaxing Certified Public Accountants (special general partnership). It is hereby announced.
Sirio Pharma Co.Ltd(300791) board of directors
January 24, 2002
